US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jun 19, 2019 (7 years ago)

Manganese Sulfate Monohydrate

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

MANGANESE SULFATE MONOHYDRATE (PFV) 0.1MG/ML INJ, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0952-10

Recalling firm
RXQ Compounding LLC
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1676-2019

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Manganese recalls

See all
Class II · Moderate risk Terminated

S-Manganese Chloride 0.1mg/Ml Mdv Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0239-2020
Class II · Moderate risk Terminated

Multi Trace

Reason Lack of sterility assurance.

Promise Pharmacy, LLC D-0439-2019
Class II · Moderate risk Ongoing

Mineral Mix Schrader

Reason Lack of Assurance of Sterility

Tri-Coast Pharmacy D-0277-2017
Class II · Moderate risk Terminated

Manganese So4 0.1mg/Ml

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1213-2016